Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy

• Principais autores: Marianna Fontana (Autor), Aldostefano Porcari (Autor), Philip N. Hawkins (Autor)
• Formato: Livro
• Publicado em: Ubiquity Press, 2023-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Transthyretin cardiac amyloidosis (ATTR-CA) has been traditionally considered a rare and inexorably fatal condition. ATTR-CA now is an increasingly recognised cause of heart failure and mortality worldwide with effective pharmacological treatments. Advances in non-invasive diagnosis, coupled with th...